{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:26:13Z","timestamp":1794360373746,"version":"4.9.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008256.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T00:00:00Z","timestamp":1465257600000}}],"reference-count":66,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008256.pub3","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T10:21:44Z","timestamp":1465294904000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Booster dose vaccination for preventing hepatitis B"],"prefix":"10.1002","volume":"2016","author":[{"given":"Jalal","family":"Poorolajal","sequence":"first","affiliation":[{"name":"School of Public Health, Hamadan University of Medical Sciences; Modeling of Noncommunicable Diseases Research Center, Department of Epidemiology; Shahid Fahmideh Ave Hamadan Hamadan Iran 6517838695"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Hooshmand","sequence":"additional","affiliation":[{"name":"School of Public Health, Hamadan University of Medical Sciences; Department of Epidemiology; Hamadan Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,7]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD008256.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1542\/peds.107.4.626","article-title":"A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory","volume":"107","author":"Cassidy","year":"2001","journal-title":"Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD008256.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0264-410X(91)90294-G","article-title":"Booster response to recombinant yeast-derived hepatitis-B vaccine in vaccinees whose anti-HBs responses were initially elicited by a plasma-derived vaccine","volume":"9","author":"Chan","year":"1991","journal-title":"Vaccine"},{"issue":"10","key":"10.1002\/14651858.CD008256.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/INF.0b013e3181f1b3b6","article-title":"A randomized, multicenter, open-label clinical trial to assess the anamnestic immune response 4 to 8 years after a primary hepatitis B vaccination series","volume":"29","author":"Diez-Domingo","year":"2010","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"3","key":"10.1002\/14651858.CD008256.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.vaccine.2012.11.037","article-title":"Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine","volume":"31","author":"Gilca","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD008256.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/INF.0b013e31826f354e","article-title":"Immune memory and immune response in children from Bulgaria 5-15 years after primary hepatitis B vaccination","volume":"32","author":"Teoharov","year":"2013","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD008256.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0264-410X(95)93126-T","article-title":"Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine","volume":"13","author":"Trivello","year":"1995","journal-title":"Vaccine"},{"issue":"8","key":"10.1002\/14651858.CD008256.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"e753","DOI":"10.1371\/journal.pone.0000753","article-title":"Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence","volume":"2","author":"Sande","year":"2007","journal-title":"Plos One"},{"issue":"28-29","key":"10.1002\/14651858.CD008256.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/S0264-410X(01)00112-8","article-title":"Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers","volume":"19","author":"Williams","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD008256.pub3-BIB0009|cit9","first-page":"207","article-title":"Effect analysis on non-and-low response infants after revaccinated hepatitis B vaccine","volume":"16","author":"Wu","year":"2010","journal-title":"Zhongguo Yi Miao He Mian Yi"},{"issue":"10","key":"10.1002\/14651858.CD008256.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4161\/hv.7.10.15990","article-title":"The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination","volume":"7","author":"Yao","year":"2011","journal-title":"Human Vaccines"},{"issue":"39","key":"10.1002\/14651858.CD008256.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1016\/j.vaccine.2012.06.078","article-title":"Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy","volume":"30","author":"Zanettia","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD008256.pub3-BIB0012|cit12","first-page":"44","article-title":"Six-year efficacy of hepatitis B revaccination: a double-blind, placebo-controlled and randomized field trial","volume":"10","author":"Zhuang","year":"1998","journal-title":"Journal of Xi'an Medical University"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2893.2003.00400.x","article-title":"Hepatitis B vaccine - do we need boosters?","volume":"10","author":"Banatvala","year":"2003","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD008256.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive - Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1016\/j.vaccine.2008.09.034","article-title":"Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report","volume":"26","author":"But","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD008256.pub3-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000100.pub3","article-title":"Vaccines for preventing hepatitis B in health-care workers","author":"Chen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD008256.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"9","key":"10.1002\/14651858.CD008256.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.inf.0000176617.63457.9f","article-title":"Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth","volume":"24","author":"Dentinger","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0021|cit21","first-page":"561-5","article-title":"Are booster immunizations needed for lifelong hepatitis B immunity?","volume":"355","author":"European Consensus Group on Hepatitis B Immunity","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.vaccine.2005.03.017","article-title":"Long-term efficacy of hepatitis B vaccine, booster policy and impact of hepatitis B virus mutants","volume":"23","author":"FitzSimons","year":"2005","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jclinepi.2004.09.013","article-title":"Uncertainty method improved on best-worst case analysis in a binary meta-analysis","volume":"58","author":"Gamble","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Gilca V De Serres G Boulianne N De Wals P Murphy D Trudeau G Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later Vaccine 2009 6048 53","DOI":"10.1016\/j.vaccine.2009.07.100"},{"issue":"4","key":"10.1002\/14651858.CD008256.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2007.01.003","article-title":"Hepatology may have problems with putative surrogate outcome measures","volume":"46","author":"Gluud","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0026|cit26","unstructured":"Gluud C Nikolova D Klingenberg SL Cochrane Hepato-Biliary Group About Cochrane (Cochrane Review Groups (CRGs)) 2016, Issue 4. Art. No.: LIVER"},{"issue":"4","key":"10.1002\/14651858.CD008256.pub3-BIB0027|cit27","first-page":"523","article-title":"Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults","volume":"73","author":"Goh","year":"1995","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0028|cit28","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GRADEpro 2008"},{"issue":"4","key":"10.1002\/14651858.CD008256.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198607243150401","article-title":"Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men","volume":"315","author":"Hadler","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0031|cit31","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0032|cit32","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"120","key":"10.1002\/14651858.CD008256.pub3-BIB0033|cit33","first-page":"1","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1440-1746.2004.03398.x","article-title":"Hepatitis B vaccine boosters: Is there a clinical need in high endemicity populations?","volume":"20","author":"John","year":"2005","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD008256.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"A1093","DOI":"10.1016\/0016-5085(95)28672-1","article-title":"Recombinant hepatitis-B vaccine long-term efficacy in hospital personnel","volume":"108","author":"Joshi","year":"1995","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD008256.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.1840180403","article-title":"Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: immunogenicity and anamnestic responses","volume":"18","author":"Lai","year":"1993","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD008256.pub3-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004790.pub2","article-title":"Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers","author":"Lee","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/S0264-410X(99)00031-6","article-title":"Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children","volume":"17","author":"Liao","year":"1999","journal-title":"Vaccine"},{"issue":"RR-16","key":"10.1002\/14651858.CD008256.pub3-BIB0039|cit39","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"5","key":"10.1002\/14651858.CD008256.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7326\/0003-4819-142-5-200503010-00008","article-title":"Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up","volume":"142","author":"McMahon","year":"2005","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008256.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/16.1.165","article-title":"Duration and efficacy of immune response to hepatitis-B vaccine in high-risk Chinese adolescents","volume":"16","author":"Mintai","year":"1993","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD008256.pub3-BIB0042|cit42","first-page":"249","article-title":"Prevalence of chronic hepatitis B infection in Iran: a review article","volume":"14","author":"Poorolajal","year":"2009","journal-title":"Journal of Research in Medical Sciences"},{"issue":"4","key":"10.1002\/14651858.CD008256.pub3-BIB0043|cit43","first-page":"293","article-title":"Seroprotection of Hepatitis B vaccine and need for booster dose: a meta-analysis","volume":"9","author":"Poorolajal","year":"2009","journal-title":"Hepatitis Monthly"},{"issue":"3","key":"10.1002\/14651858.CD008256.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.vaccine.2009.10.068","article-title":"Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis","volume":"28","author":"Poorolajal","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"10.1002\/14651858.CD008256.pub3-BIB0045|cit45","first-page":"260","article-title":"European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus","volume":"10","author":"Puro","year":"2005","journal-title":"Euro Surveillance"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0046|cit46","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD008256.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"2","key":"10.1002\/14651858.CD008256.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1542\/peds.2007-0131","article-title":"Differences in response to a hepatitis B vaccine booster dose amongAlaskan children and adolescents vaccinated during infancy","volume":"120","author":"Samandari","year":"2007","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD008256.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0050|cit50","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0051|cit51","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0052|cit52","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"issue":"16","key":"10.1002\/14651858.CD008256.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1001\/jama.1989.03420160094029","article-title":"Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population","volume":"261","author":"Wainwright","year":"1989","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/infdis\/175.3.674","article-title":"Protection provided by hepatitis B vaccine in a Yupik Eskimo population - Results of a 10-year study","volume":"175","author":"Wainwright","year":"1997","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1016\/S0264-410X(01)00019-6","article-title":"Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine","volume":"19","author":"Watson","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD008256.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in a random-effects meta-analysis","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bmj.325.7364.569","article-title":"Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children","volume":"325","author":"Whittle","year":"2002","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0059|cit59","unstructured":"World Health Organization Introduction of hepatitis B vaccine into childhood immunization services www.who.int\/immunization\/documents\/WHO_VB_01.31\/en\/"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0060|cit60","unstructured":"World Health Organization Hepatitis B www.who.int\/csr\/disease\/hepatitis\/whocdscsrlyo20022\/en\/"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0061|cit61","unstructured":"World Health Organization Expanded program on immunization: measles and hepatitis B www2.wpro.who.int\/rcm\/en\/archives\/rc54\/rc_resolutions\/wpr_rc54_r03.htm"},{"issue":"2","key":"10.1002\/14651858.CD008256.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.inf.0000050463.28917.25","article-title":"Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination","volume":"22","author":"Williams","year":"2003","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"3","key":"10.1002\/14651858.CD008256.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/hep.510290327","article-title":"Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children","volume":"29","author":"Yuen","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD008256.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S1542-3565(04)00384-2","article-title":"18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children","volume":"2","author":"Yuen","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD008256.pub3-BIB0065|cit65","first-page":"97","article-title":"Five-year follow-up of immune response to hepatitis B vaccine in juveniles","volume":"106","author":"Zhang","year":"1993","journal-title":"Chinese Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD008256.pub3-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008256.pub2","article-title":"Booster dose vaccination for preventing hepatitis B","author":"Poorolajal","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008256.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T20:07:08Z","timestamp":1636229228000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008256.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,7]]},"references-count":66,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008256.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,7]]}}}